Acta Poloniae Pharmaceutica - Drug Research, cilt.54, sa.5, ss.363-370, 1997 (SCI-Expanded)
Eight new 3-alkyl(aryl)-4-arylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-ones were synthesized and characterised by elemental analysis, 1H NMR, IR and UV spectra. Seven new and 34 recently reported derivatives of 4,5-dihydro-1H-1,2,4-triazol-5-one ring were screened for their antitumor activities.